Neuropeptide Y: anatomical distribution and possible function in mammalian nervous system.

[1]  L. Edvinsson Functional role of perivascular peptides in the control of cerebral circulation , 1985, Trends in Neurosciences.

[2]  P. Emson,et al.  Distribution of neuropeptide Y in the lower brainstem: an immunohistochemical analysis , 1985, Brain Research.

[3]  J. Polak,et al.  Presence of the predicted C-flanking peptide of neuropeptide Y (CPON) in tissue extracts , 1985, Neuropeptides.

[4]  J. Powell,et al.  An arcuato-paraventricular and -dorsomedial hypothalamic neuropeptide Y-containing system which lacks noradrenaline in the rat , 1985, Brain Research.

[5]  T. Hökfelt,et al.  Tissue-specific depletion of NPY-like immunoreactivity by reserpine. , 1985, Acta physiologica Scandinavica.

[6]  S. Leibowitz,et al.  Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus. , 1984, Life sciences.

[7]  T. O'donohue,et al.  Coexistence of neuropeptide Y and somatostatin in rat and human cortical and rat hypothalamic neurons , 1984, Neuroscience Letters.

[8]  A. Saria,et al.  Evidence for specific neuropeptide Y-binding sites in rat brain synaptosomes. , 1984, European journal of pharmacology.

[9]  J. Morley,et al.  Neuropeptide Y: A potent inducer of consummatory behavior in rats , 1984, Peptides.

[10]  F. Sundler,et al.  Neuropeptide Y in the thyroid gland: neuronal localization and enhancement of stimulated thyroid hormone secretion. , 1984, Endocrinology.

[11]  P. Emson,et al.  Neuropeptide Y: immunocytochemical localization to and effect upon feline pial arteries and veins in vitro and in situ. , 1984, Acta physiologica Scandinavica.

[12]  S. Kalra,et al.  Norepinephrine-like effects of neuropeptide Y on LH release in the rat. , 1984, Life sciences.

[13]  F. Schon,et al.  PRESENCE OF NEUROPEPTIDE Y IN HUMAN CIRCLE OF WILLIS AND ITS POSSIBLE ROLE IN CEREBRAL VASOSPASM , 1984, The Lancet.

[14]  L. Edvinsson,et al.  Interaction of peptides present in perivascular nerves on the smooth muscle of cat cerebral arteries and on the stimulation-evoked efflux of 3H-noradrenaline. , 1984, Journal of autonomic pharmacology.

[15]  A. Franco‐Cereceda,et al.  Effects of neuropeptide Y (NPY) on mechanical activity and neurotransmission in the heart, vas deferens and urinary bladder of the guinea-pig. , 1984, Acta physiologica Scandinavica.

[16]  P S Kalra,et al.  Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. , 1984, Endocrinology.

[17]  I. Ferrier,et al.  Elevation of neuropeptide Y (NPY) in substantia innominata in Alzheimer's type dementia , 1984, Journal of the Neurological Sciences.

[18]  P. Mantyh,et al.  Neuropeptides are present in projection neurones at all levels in visceral and taste pathways: from periphery to sensory cortex , 1984, Brain Research.

[19]  S. Leibowitz,et al.  Noradrenergic feeding elicited via the paraventricular nucleus is dependent upon circulating corticosterone , 1984, Physiology & Behavior.

[20]  J. Polak,et al.  Neuropeptide tyrosine (NPY) immunoreactivity in norepinephrine-containing cells and nerves of the mammalian adrenal gland. , 1984, Endocrinology.

[21]  J. Lundberg,et al.  Neuropeptide Y (NPY) depresses the secretion of 3H-noradrenaline and the contractile response evoked by field stimulation, in rat vas deferens. , 1984, Acta physiologica Scandinavica.

[22]  T. Hökfelt,et al.  Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat , 1984, Neuroscience.

[23]  P. Emson,et al.  NPY — a new member of the pancreatic polypeptide family , 1984, Trends in Neurosciences.

[24]  P. Emson,et al.  Demonstration of a neuropeptide Y-like immunoreactivity in human phaeochromocytoma extracts , 1984, Regulatory Peptides.

[25]  H. Zimmermann,et al.  Ecto-adenosine triphosphatase activity at the cholinergic nerve endings of the Torpedo electric organ. , 1983, Life sciences.

[26]  P. Emson,et al.  Neuropeptide Y: Cerebrovascular innervation an vasomotor effects in the cat , 1983, Neuroscience Letters.

[27]  T. Hökfelt,et al.  High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man , 1983, Neuroscience Letters.

[28]  J. Polak,et al.  Neuropeptide y-immunoreactive nerves in the uvea of guinea pig and rat , 1983, Neuroscience Letters.

[29]  B. Johansson,et al.  Effect of sympathetic nerve stimulation and adrenoceptor blockade on pial arterial and venous calibre and on intracranial pressure in the cat. , 1983, Acta physiologica Scandinavica.

[30]  T. Adrian,et al.  Neuropeptide Y (NPY) in the adrenal gland. , 1983, Journal of the autonomic nervous system.

[31]  P. McHugh The control of gastric emptying. , 1983, Journal of the autonomic nervous system.

[32]  S. Kalra,et al.  Neural regulation of luteinizing hormone secretion in the rat. , 1983, Endocrine reviews.

[33]  P. Emson,et al.  Neuropeptide Y in the female reproductive tract of the rat. Distribution of nerve fibres and motor effects , 1983, Neuroscience Letters.

[34]  T. Adrian,et al.  NEUROPEPTIDE Y IN PHAEOCHROMOCYTOMAS AND GANGLIONEUROBLASTOMAS , 1983, The Lancet.

[35]  T. Crow,et al.  Neuropeptide Y distribution in the rat brain. , 1983, Science.

[36]  T. Adrian,et al.  Reduction of neuropeptide Y (NPY) in the rabbit iris-ciliary body after chronic sympathectomy. , 1983, Experimental eye research.

[37]  S. Bloom,et al.  Neuropeptide Y (NPY) reduces myocardial perfusion and inhibits the force of contraction of the isolated perfused rabbit heart , 1983, Regulatory Peptides.

[38]  S. Kalra,et al.  Effects of intraventricular administration of catecholamines on luteinizing hormone release in morphine-treated rats. , 1983, Endocrinology.

[39]  J. Morley,et al.  Opioid modulation of appetite , 1983, Neuroscience & Biobehavioral Reviews.

[40]  T. Hökfelt,et al.  Central administration of neuropeptide Y induces hypotension bradypnea and EEG synchronization in the rat. , 1983, Acta physiologica Scandinavica.

[41]  J. Polak,et al.  NEUROPEPTIDE TYROSINE (NPY)—A MAJOR CARDIAC NEUROPEPTIDE , 1983, The Lancet.

[42]  A. Levine,et al.  THE CENTRAL CONTROL OF APPETITE , 1983, The Lancet.

[43]  T. Hökfelt,et al.  Neuropeptide Y (NPY)- and FMRFamide neuropeptide-like immunoreactivities in catecholamine neurons of the rat medulla oblongata. , 1983, Acta physiologica Scandinavica.

[44]  L. Edvinsson Sympathetic control of cerebral circulation , 1982, Trends in Neurosciences.

[45]  J. Lundberg,et al.  Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to alpha-adrenoceptor blockade. , 1982, Acta physiologica Scandinavica.

[46]  S. Chierchia,et al.  Coronary artery spasm: demonstration, definition, diagnosis, and consequences. , 1982, Progress in cardiovascular diseases.

[47]  T. Hökfelt,et al.  Neuropeptide coexistence in human cortical neurones , 1982, Nature.

[48]  D. Jacobowitz,et al.  Bovine pancreatic polypeptide-like immunoreactivity in brain and peripheral nervous system: Coexistence with catecholaminergic nerves , 1982, Peptides.

[49]  P. Sawchenko,et al.  Evidence for vagal involvement in the eating elicited by adrenergic stimulation of the paraventricular nucleus , 1981, Brain Research.

[50]  J. Morley,et al.  Neuroendocrine control of thyrotropin secretion. , 1981, Endocrine reviews.

[51]  D. Jacobowitz,et al.  The distribution of bovine pancreatic polypeptide-like immunoreactive neurons in rat brain , 1981, Peptides.

[52]  S. Hunt,et al.  Presence of avian pancreatic polypeptide-like immunoreactivity in catecholamine and methionine-enkephalin-containing neurones within the central nervous system , 1981, Neuroscience Letters.

[53]  J. Morley The neuroendocrine control of appetite: the role of the endogenous opiates, cholecystokinin, TRH, gamma-amino-butyric-acid and the diazepam receptor. , 1980, Life sciences.

[54]  V. Mutt,et al.  Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides , 1980, Nature.

[55]  Derek Meyers,et al.  MORTALITY AND WATER HARDNESS , 1975, The Lancet.

[56]  J. Wilkinson,et al.  Effect of beta-chloroethylamine hydrochlorides in leukaemia, Hodgkin's disease, and polycythaemia vera; report on 18 cases. , 1947, Lancet.

[57]  J. Morley,et al.  The Pharmacology of Eating Behavior , 1985 .

[58]  C. Wahlestedt,et al.  Neuropeptide Y in the Gut and Pancreas: Distribution and Possible Vasomotor Function , 1984 .